Treatment of severe human metapneumovirus (hmpv) pneumonia in an immunocompromised child with oral ribavirin and ivig

Journal of Pediatric Hematology/Oncology

Volumn 35, Issue 7, 2013, Pages

  Kitanovski, Lidija ^a   Kopriva, Silvester ^b   Pokorn, Marko ^a   Dolničar, Majda B ^a   Rajić, Vladan ^a   Stefanović, Milica ^a   Jazbec, Janez ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b Department of Pediatric Surgery and Intensive Care ^*  (United States)

Author keywords

Burkitt lymphoma; human metapneumovirus; intravenous immunoglobulin; oral ribavirin

Indexed keywords

ACICLOVIR; C REACTIVE PROTEIN; CASPOFUNGIN; CEFTRIAXONE; CLARITHROMYCIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; FLUCONAZOLE; IMMUNOGLOBULIN; PIPERACILLIN PLUS TAZOBACTAM; PROCALCITONIN; RIBAVIRIN; VANCOMYCIN;

ARTICLE; ASSISTED VENTILATION; BLOOD CULTURE; BRONCHOSCOPY; BURKITT LYMPHOMA; CANCER CHEMOTHERAPY; CANCER STAGING; CASE REPORT; CHILD; CHLAMYDIA; CLINICAL PROTOCOL; CRACKLE; DISEASE COURSE; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EXTUBATION; FEBRILE NEUTROPENIA; FEMALE; GENERAL CONDITION DETERIORATION; HEAD AND NECK TUMOR; HERPETIC STOMATITIS; HORMONE BLOOD LEVEL; HUMAN; HUMAN METAPNEUMOVIRUS INFECTION; HYPOXEMIA; IMMUNE DEFICIENCY; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN BLOOD LEVEL; INCIDENTAL FINDING; INTENSIVE CARE UNIT; LEUKOCYTE COUNT; LOWER RESPIRATORY TRACT; LUNG INFILTRATE; LUNG LAVAGE; MYCOBACTERIUM TUBERCULOSIS; MYCOPLASMA PNEUMONIAE; NEUTROPENIA; NEUTROPHIL COUNT; OXYGEN NASAL CANNULA; OXYGEN THERAPY; PNEUMOCYSTIS JIROVECI; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESPIRATORY TRACT INFLAMMATION; SEROLOGY; STREPTOCOCCUS INFECTION; STREPTOCOCCUS SALIVARIUS; TACHYPNEA; THORAX RADIOGRAPHY; THROAT CULTURE; TREATMENT RESPONSE; VIRUS PNEUMONIA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIVIRAL AGENTS; BURKITT LYMPHOMA; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULINS, INTRAVENOUS; METAPNEUMOVIRUS; PARAMYXOVIRIDAE INFECTIONS; PNEUMONIA, VIRAL; RIBAVIRIN; TREATMENT OUTCOME;

EID: 84885183818     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3182915d2d     Document Type: Article

References (20)

1. van den Hoogen BG, de Jong JC, Groen J, et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med. 2001;7:719-724.
2. Peret TC, Boivin G, Li Y, et al. Characterization of human metapneumoviruses isolated from patients in North America. J Infect Dis. 2002;185:1660-1663.
3. Woessmann W, Seidemann K, Mann G, et al. The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95. Blood. 2005;105:948-958.
4. Williams JV, Martino R, Rabella N, et al. A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections. J Infect Dis. 2005;192:1061-1065.
5. Shahda S, Carlos WG, Kiel PJ, et al. The human metapneumovirus: a case series and review of the literature. Transpl Infect Dis. 2011;13:324-328.
6. Ali M, Baker J, Richardson SE, et al. Human Metapneumovirus Infection in Children With Cancer. Blood (ASH Annual Meeting Abstracts). 2010;116:Abstract 3910.
7. Debiaggi M, Canducci F, Sampaolo M, et al. Persistent symptomless human metapneumovirus infection in hematopoietic stem cell transplant recipients. J Infect Dis. 2006;194:474-478.
8. Englund JA, Boeckh M, Kuypers J, et al. Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients. Ann Intern Med. 2006;144:344-349.
9. Pelletier G, Dery P, Abed Y, et al. Respiratory tract reinfections by the new human metapneumovirus in an immunocompromised child. Emerg Infect Dis. 2002;8:976-978.
10. Hamelin ME, Prince GA, Boivin G. Effect of ribavirin and glucocorticoid treatment in a mouse model of human metapneumovirus infection. Antimicrob Agents Chemother. 2006;50:774-777.
11. Sookoian S, Castan? o G, Flichman D, et al. Effects of ribavirin on cytokine production of recall antigens and phytohemaglutinin-stimulated peripheral blood mononuclear cells. (Inhibitory effects of ribavirin on cytokine production). Ann Hepatol. 2004;3:104-107.
12. Safdar A. Immune modulatory activity of ribavirin for serious human metapneumovirus disease: early i. v. therapy may improve outcomes in immunosuppressed SCT recipients. Bone Marrow Transplant. 2008;41:707-708.
13. Raza K, Ismailjee SB, Crespo M, et al. Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirin. J Heart Lung Transplant. 2007;26:862-864.
14. Kamble RT, Bollard C, Demmler G. Human metapneumovirus infection in a hematopoietic transplant recipient. Bone Marrow Transplant. 2007;40:699-700.
15. Bonney D, Razali H, Turner A, et al. Successful treatment of human metapneumovirus pneumonia using combination therapy with intravenous ribavirin and immune globulin. Br J Haematology. 2009;145:665-678.
16. Shachor-Meyouhas Y, Kassis I, Ben-Barak A. Treatment with oral ribavirin and IVIG of severe human metapneumovirus pneumonia (HMPV) in immunecompromised child. Pediatr Blood Cancer. 2011;57:350-351.
17. Connor E, Morrison S, Lane J, et al. Safety, tolerance and pharmacokinetics of systemic ribavirin in children with human immunodeficiency virus infection. Antimicrob Agents Chemother. 1993;37:532-539.
18. Wyde PR, Chetty SN, Jewell AM, et al. Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro. Antiviral Res. 2003;60:51-59.
19. Pelaez A, Lyon GM, Force SD, et al. Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection. Heart Lung Transplant. 2009;28:67-71.
20. Egli A, Bucher C, Dumoulin A, et al. Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation. Infection. 2012;40:677-684.